The beginning of Ag404: Leading the Way in Colloidal Silver Advancements
In 1998, American Biotech Labs introduced a true colloid. American Biotech labs miracle particle is a solid silver core coated with Ag404 ranging in size from 5-15 nano meters. A proprietary technology that ushered in a new era in the development of colloidal silver. American Biotech Labs, renowned for its scientific expertise and commitment to innovation, aimed to surpass traditional colloidal silver products in terms of purity, efficiency, and controlled release mechanisms. With Ag404, they succeeded in creating a colloidal silver product that sets new industry standards.
The foundation of Ag404 technology lies in its precise scientific process for creating silver nanoparticles, as outlined in a seminal research paper [1]. This meticulous approach ensures unparalleled accuracy, resulting in the purest colloidal silver available in the market today.
Unveiling the Power of Ag404 Molecule: Optimizing Bioactivity and Safety
One of the standout features of Ag404 technology is its ability to work safely and continuously harnessing the full potential benefits of silver. This unique characteristic sets Ag404 apart from other colloidal silver technologies, providing users with consistent and reliable results without the concerns commonly associated with alternative products.
The groundbreaking study [2] sheds light on the exceptional bioactivity of Ag404 nanoparticles. This research highlights the surface area and bioactivity maximization achieved by Ag404, resulting in enhanced antimicrobial properties, immune system support, and wound healing capabilities. These remarkable findings validate the potential of Silver Biotics Ag404 technology as a powerful tool for promoting overall well-being.
Furthermore, the controlled release mechanism of Ag404 technology addresses a longstanding concern associated with some colloidal silver products—silver accumulation in the body. The research conducted [2] underscores the effectiveness of Ag404 in the silver particle’s ability to steal electrons from pathogens, minimizing the risk of accumulation while ensuring sustained antimicrobial effects. SilverSolR or Ag404 has also been shown to leave the body within 36-72 hours.[2]
The Advantages of Silver Biotics Ag404 Technology
Silver Biotics, powered by Ag404 also known as SilverSolR technology, stands at the forefront of colloidal silver products, setting new benchmarks for quality and effectiveness. This advanced technology offers numerous advantages, making it the go-to choice for biohackers and health enthusiasts seeking optimal well-being.
Moreover, the research conducted [1] highlights the continuous action of Ag404, which ensures consistent and reliable results. This mechanism along with the particles ability to leave the body within 36-72 hours is what makes Silver Biotics stand out from the rest. With Silver Biotics, users can experience the benefits of silver without compromising their well-being!
Silver Biotics Ag404 technology has undergone comprehensive testing and quality control measures, as mentioned in the study [1]). This commitment to rigorous scientific evaluation guarantees that each Silver Biotics product meets the highest standards of quality, safety, and efficacy.
The Gold Or should we say Silver Standard
Ultimately, the Ag404 technology developed by American Biotech Labs, as supported by the research studies cited below, has propelled Silver Biotics to the forefront of colloidal silver products. Its unmatched purity, controlled release mechanism, and exceptional antimicrobial properties make it the gold standard in the industry (or I should say Silver Standard). By embracing the power of Silver Biotics Ag404 technology, you can optimize your well-being and unlock a whole new level of vitality and balance. Choose Silver Biotics! It’s every Biohackers dream; backed by scientific research and over one million units sold, experience the extraordinary benefits of the most advanced colloidal silver on the market!
References:
[1] In Vivo Human Time-Exposure Study of Orally Dosed Commercial Silver Nanoparticles https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877176/ [2] Ultra dilute ag-aqua sols with extraordinary bactericidal properties https://lifesilver.com/facts/Rustum_Roy_et_al_study.pdf#:~:text=We%20first%20establish%20the%20literature%20on%20the%20use,to%20their%20field%20for%20new%2C%20safer%20health%20vectors.Other studies concerning the use of silver nanoparticles
1. The Project on Emerging Nanotechnologies [Accessed: 01/12/2012];Nanotech-enabled Consumer Products Continue to Rise. http://www.nanotechproject.org/news/archive/9231/
2. Grainger DW. Nanotoxicity assessment: all small talk? Adv Drug Deliv Rev. 2009;61(6):419–21. [PMC free article] [PubMed] [Google Scholar]
3. Oberdörster G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med. 2010;267(1):89–105. [PubMed] [Google Scholar]
4. Becker H, Herzberg F, Schulte A, Kolassa-Gehring M. The carcinogenic potential of nanoparticles, their release from products and options for regulating them. Int J Hyg Environ Health. 2011;214(3):231–8. [PubMed] [Google Scholar]
5. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol. 2010;40(4):328–46. [PubMed] [Google Scholar]
6. Samberg ME, Orndorff PE, Monteiro-Riviere N. Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods. Nanotoxicol. 2011;5(2):244–53. [PubMed] [Google Scholar]
7. Roy R, Hoover MR, Bhalla AS, Slawecki T, Dey S, Cao W, et al. Ultradilute Ag-aquasols with extraordinary bacteriocidal properties: Role of the system Ag-0-H20. Mat Resear Innovat. 2007;11:3–18. [Google Scholar] 8. Atiyeh BS, Costagliola M, Hayek SN, Dibbo SA. Effect of silver on burn wound infection control and healing; review of the literature. Burns. 2007;33:139–48. [PubMed] [Google Scholar]
9. Elechiguerra JL, Burt J, Morones JR, Camacho-Bragado A, Gao X, Lara HH, Yacaman MJ. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol. 2005;3:6. [PMC free article] [PubMed] [Google Scholar] 10. Bhol KC, Alroy J, Schechter PJ. Anti-inflammatory effects of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model. Clin Exp Dermatol. 2004;29:282–7. [PubMed] [Google Scholar] 11. Takenaka S, Karg E, Roth C, Schultz H, Ziesenis A, Heinzmann U, et al. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect. 2001;109(Suppl 4):547–51. [PMC free article] [PubMed] [Google Scholar]
12. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B. 2008;112(43):13608–19. [PubMed] [Google Scholar]
13. Soto K, Garza KM, Murr LE. Cytotoxic effects of aggregated nanomaterials. Acta Biomater. 2007;3:351–8. [PubMed] [Google Scholar]
14. Sung JH, Ji JH, Yoonn JU, Kim DS, Song MY, Jeong J, et al. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal Toxicol. 2008;20(6):567–74. [PubMed] [Google Scholar]
15. Hussain SM, Hess KL, Gear hart JM, Geiss KT, Schlarger JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol in Vitro. 2005;19:975–83. [PubMed] [Google Scholar]
16. Arora S, Jain J, Rajwade JM, Paknikar KM. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol Appl Pharmacol. 2009;236:310–8. [PubMed] [Google Scholar] 17. Park EJ, Yi J, Kim Y, Choi K, Park K. Silver nanoparticles induce cytoxicity by a Trojan-horse type mechanism. Toxicol in Vitro. 2010;24:872–8. [PubMed] [Google Scholar]
18. Kawata K, Osawa M, Okabe S. In vitro toxicity of silver nanoparticles at noncytotoxic doses in HepG2 human hepatoma cells. Environ Sci Technol. 2009;43:6046–51. [PubMed] [Google Scholar] 19. Hussain SM, Javorina AK, Schrand AM, Duhart HM, Ali SF, Schlager JJ. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci. 2006;92(2):456–63. [PubMed] [Google Scholar]
20. Rosas-Hernandeza H, Jimenez-Badilloa S, Martinez-Cuevasa PP, Gracia-Espino E, Terrones H, Terrones M, et al. Effects of 45-nm silver nanoparticles on coronary endothelial cells and isolated rat aortic rings. Toxicol Lett. 2009;191(2-3):305–13. [PubMed] [Google Scholar]
21. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci. 2005;88:412–9. [PMC free article] [PubMed] [Google Scholar] 22. Ahamed M, Karns M, Goodson M, Rowe J, Hussain SM, Schlager JJ, Hong Y. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharmacol. 2008;233(3):404–10. [PubMed] [Google Scholar]
23. Holladay: 7,135,195 United States Patent USP. Christensen RJ. H. “Treatment of humans with colloidal silver composition” 2006. Holladay: 6,214,299 United States Patent. Christensen RJ. H. Apparatus and method for producing antimicrobial silver solution. 2001.
